{
    "organizations": [],
    "uuid": "2a12f18ec8469d42c2734818226217efcc2484d5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-emerald-health-therapeutics-entere/brief-emerald-health-therapeutics-entered-5149-jv-to-be-called-emerald-health-naturals-with-emerald-health-bioceuticals-idUSFWN1RU0SH",
    "ord_in_thread": 0,
    "title": "BRIEF-Emerald Health Therapeutics - Entered 5149 JV, To Be Called Emerald Health Naturals, With Emerald Health Bioceuticals",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 17 (Reuters) - Emerald Health Therapeutics Inc :\n* EMERALD HEALTH THERAPEUTICS - ENTERED 51:49 JV, TO BE CALLED EMERALD HEALTH NATURALS, WITH EMERALD HEALTH BIOCEUTICALS\n* EMERALD HEALTH THERAPEUTICS INC - EHN HAS AGREED TO ACQUIRE ASSETS OF GAB INNOVATIONS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-04-17T19:08:00.000+03:00",
    "crawled": "2018-04-18T18:07:02.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "emerald",
        "health",
        "therapeutic",
        "inc",
        "emerald",
        "health",
        "therapeutic",
        "entered",
        "jv",
        "called",
        "emerald",
        "health",
        "natural",
        "emerald",
        "health",
        "bioceuticals",
        "emerald",
        "health",
        "therapeutic",
        "inc",
        "ehn",
        "agreed",
        "acquire",
        "asset",
        "gab",
        "innovation",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}